Approvals/TGA/RAPIVAB peramivir 200 mg / 20 mL concentrate for intravenous infusion glass vial

Approved

STANDARD

RAPIVAB peramivir 200 mg / 20 mL concentrate for intravenous infusion glass vial

Biocelect Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 0fbeacf77b52c3fa
Product Name: RAPIVAB peramivir 200 mg / 20 mL concentrate for intravenous infusion glass vial
Artg Id: 285559
Artg Name: RAPIVAB peramivir 200 mg / 20 mL concentrate for intravenous infusion glass vial
Sponsor: Biocelect Pty Ltd
Company Detail Path: /organization/biocelect-pty-ltd
Artg Date: 2018-03-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/af4acc9033b30e0079b7074191040cc4.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/11dcb4ae488d9659632d25bc99ac4968.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

0fbeacf77b52c3fa

Type

Standard